Details of the Drug
General Information of Drug (ID: DMNR3YL)
| Drug Name |
(+/-)-2-Phenylthiomorpholine
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
2-phenylthiomorpholine; 77082-31-6; 2-PHENYL-THIOMORPHOLINE; CHEMBL608438; Thiomorpholine,2-phenyl-; (+/-)-2-Phenylthiomorpholine; AC1NMBWZ; AC1Q1ICC; Thiomorpholine, 2-phenyl-; SCHEMBL1636929; CTK5E3816; DTXSID20407436; MolPort-001-791-006; SRYHBJDVLOEJNP-UHFFFAOYSA-N; 2-Phenyl-thiomorpholine, AldrichCPR; BDBM50307369; AKOS006230101; MCULE-8074427790; QC-5067; NE56940; KB-69531; EN300-80273
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 179.28 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.7 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


